Iluvatar CoreX
PrivateLast Round
Series D
Extension
Sep 18, 2024
Est. Valuation
$1B
Total Funding Raised
$334M
Company Overview
Iluvatar CoreX is a semiconductor company that develops general-purpose computing on graphics processing units (GPGPUs) for use in artificial intelligence and high-performance computing.
Sector
AI, Data & Cloud Infrastructure
Verticals
Semiconductors, AI Training Infrastructure, Computing Hardware, Edge Computing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iluvatar CoreX Comps
Public and private peers based on sector, stage, and business model.
Iluvatar CoreX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Sep 18, 2024 | ||||
| Series D | Jan 11, 2024 | ||||
| Series C Extension | Jul 13, 2022 | ||||
| Series C | Mar 1, 2021 | ||||
| Series B | Sep 19, 2019 |
Iluvatar CoreX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centurium Capital | Series D, Series C, Series B |
| Cedarlake Capital | Series C |
| Teacher Retirement System of Texas | Series D |
| HongShan | Series D |
Iluvatar CoreX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iluvatar CoreX's valuation, stock price, and market status.